| 摘要、提要註: |
"Drug Development for Cancer and Diabetes: A Path to 2030 focuses on new developments in the discovery of drugs for the treatment of cancer and diabetes. This new book presents important recent advances, emerging trends, and novel innovations for these two world-leading diseases. It is structured in two parts. Part I consists of chapters that explores cancer cell cycle checkpoints, cancer biomarkers, essential drug properties, stages in anti-cancer drug development, and various bioactives that are effective against cancer. Part II presents a complete coverage of important advances and research discoveries in antidiabetic drugs. It details the potentials of medicinal plants and phytocompounds as sources for antidiabetic drugs and highlights the ethnobotanical basis of the compounds. With chapters written by professionals in the field of phytochemistry and pharmacology from key institutions around the world, this volume provides a wide coverage and will be useful especially for scientists in pharmaceutical field. Key features: presents novel discoveries and mechanisms for the treatment of cancer and diabetes, details the role of plants for the treatment and management of cancer and diabetes, discusses the role of phytocompounds as ligands for cancer and diabetic targets, reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs, explores the green biosynthesis of nanoparticles and their efficiency in the treatment of diabetes and cancer."-- |